DÄ internationalArchive18/2007Perioperative Bridging of Oral Anticoagulation Therapy

Review article

Perioperative Bridging of Oral Anticoagulation Therapy

Dtsch Arztebl 2007; 104(18): A-1237

Bauersachs, R M; Schellong, S; Haas, S; Gogarten, W; Riess, H; Omran, H

For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.

1. Douketis JD, Johnson JA, Turpie AG: Low-molecular-weight-heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen. Arch Intern Med 2004; 164:1319–26. MEDLINE
2. Jafri SM: Periprocedural thromboprophylaxis in patients receiving chronic anticoagulation therapy. Am Heart J 2004; 147: 3–15. MEDLINE
3. Spandorfer J: The management of anticoagulation before and after procedures. Med Clin North Am 2001; 85: 1109–16. MEDLINE
4. Omran H, Hammerstingl C, Schmidt H, von der Recke G, Paar WD, Luderitz B: A prospective and randomized comparison of the safety and effects of therapeutic levels of enoxaparin versus unfractionated heparin in chronically anticoagulated patients undergoing elective cardiac catheterization. Thromb Haemost 2003; 90: 267–71. MEDLINE
5. Dunn AS, Turpie AG: Perioperative management of patients receiving oral anticoagulants: a systematic review. Arch Intern Med 2003; 163: 901–8. MEDLINE
6. Mehra P, Cottrell DA, Bestgen SC, Booth DF: Management of heparin therapy in the high-risk, chronically anticoagulated, oral surgery patient: a review and a proposed nomogram. J Oral Maxillofac Surg 2000; 58: 198–202. MEDLINE
7. Gerson LB, Gage BF, Owens DK, Triadafilopoulos G: Effect and outcomes of the ASGE guidelines on the periendoscopic management of patients who take anticoagulants. Am J Gastroenterol 2000; 95: 1717–24. MEDLINE
8. Bierbaum BE, Callaghan JJ, Galante JO, Rubash HE, Tooms RE, Welch RB: An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 1999; 81: 2–10. MEDLINE
9. Wahl MJ: Dental surgery in anticoagulated patients. Arch Intern Med 1998; 158: 1610–6. MEDLINE
10. Montalescot G, Polle V, Collet JP et al.: Low molecular weight heparin after mechanical heart valve replacement. Circulation 2000; 101: 1083–6. MEDLINE
11. Stellbrink C, Nixdorff U, Hofmann T et al.: Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial. Circulation 2004; 109: 997–1003. MEDLINE
12. Fanikos J, Tsilimingras K, Kucher N, Rosen AB, Hieblinger MD, Goldhaber SZ: Comparison of efficacy, safety, and cost of low-molecular-weight heparin with continuous-infusion unfractionated heparin for initiation of anticoagulation after mechanical prosthetic valve implantation. Am J Cardiol 2004; 93: 247–50. MEDLINE
13. Halbritter KM, Wawer A, Beyer J, Oettler W, Schellong SM: Bridging anticoagulation for patients on long-term vitamin-K-antagonists. A prospective 1 year registry of 311 episodes. J Thromb Haemost 2005; 3: 2823–5. MEDLINE
14. Spyropoulos A, Dunn A, Turpie A et al.: Perioperative bridging therapy with unfractionated heparin or low-molecular-weight heparin in patients with mechanical heart valves on long term oral anticoagulants: Results from the REGIMEN registry [abstract A832]. J Am Coll Cardiol 2005; 45: 352.
15. Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E: The pharmacology and management of the vitamin-K-antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 204–33. MEDLINE
16. Kearon C, Hirsh J: Management of anticoagulation before and after elective surgery. N Engl J Med 1997; 336: 1506–11. MEDLINE
17. Kearon C: Long-term management of patients after venous thromboembolism. Circulation 2004; 110: 10–8. MEDLINE
18. Katholi RE, Nolan SP, McGuire LB: The management of anticoagulation during noncardiac operations in patients with prosthetic heart valves. A prospective study. Am Heart J 1978; 96: 163–5. MEDLINE
19. Spandorfer JM, Lynch S, Weitz HH, Fertel S, Merli GJ: Use of enoxaparin for the chronically anticoagulated patient before and after procedures. Am J Cardiol 1999; 84: 478–80. MEDLINE
20. Johnson JA, Turpie AG: Temporary discontinuation of oral anticoagulants: role of low-molecular-weight heparin. Thromb Haemost 2001; 85: 2323.
21. Ferreira I, Dos L, Tornos P, Nicolau I, Permanyer-Miralda G, Soler-Soler J: Experience with enoxaparin in patients with mechanical heart valves who must withhold acenocumarol. Heart 2003; 89: 527–30. MEDLINE
22. Omran H, Hammerstingl C, Schmidt H, Lüderitz B: Periinterventionelles Management bei oral antikoagulierten Patienten [Abstract L6]. Hämostaseologie 2005; 25(1): 1–54.
23. Dunn A, Spyropoulos A, Sirko S, Turpie A: Perioperative bridging therapy with enoxaparin in patients requiring interruption of long term anticoagulant therapy: a multicentre cohort study. Blood 2004; 104(abstract) 1761.
24. Hammerstingl C, Schlang G, Bernhardt P, Schmidt H, Omran H: Einsetzbarkeit niedermolekularer Heparine bei Umstellung einer oralen Antikoagulation vor Interventionen mit erhöhtem Blutungsrisiko: Das „Bonn-Register“ – Erfahrungen mit 200 Patienten. Z Kardiol 2004; 93(Suppl): 281–2.
25. Kovacs MJ, Kearon C, Rodger M et al.: Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin. Circulation 2004; 110: 1658–63. MEDLINE
e1. Heit JA: Perioperative management of the chronically anticoagulated patient. J Thromb Thrombolysis 2001; 12: 81–7. MEDLINE
e2. Prandoni P, Lensing AW, Piccioli A et al.: Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood 2002; 100: 3484–8. MEDLINE
e3. Dotan ZA, Mor Y, Leibovitch I et al.: The efficacy and safety of perioperative low molecular weight heparin substitution in patients on chronic oral anticoagulant therapy undergoing transurethral prostatectomy for bladder outlet obstruction. J Urol 2002; 168: 610–3; discussion 614. MEDLINE
e4. Douketis JD: Perioperative anticoagulation management in patients who are receiving oral anticoagulant therapy: a practical guide for clinicians. Thromb Res 2002; 108: 3–13. MEDLINE
e5. Watts SA, Gibbs NM: Outpatient management of the chronically anticoagulated patient for elective surgery. Anaesth Intensive Care 2003; 31: 145–54.
e6. Galla J, Fuhs B: Outpatient anticoagulation protocol for mechanical valve recipients undergoing non-cardiac surgery. J Am Coll Cardiol 2000; 35: 531A; 1114–64; abstract.
e7. Turpie AG, Douketis J: Enoxaparin is effective and safe as bridging anticoagulation in patients with a mechanical prosthetic heart valve who require temporary interruption of warfarin because of surgery or an invasive procedure. Blood 2004; 104: abstract 703.
e8. Tinmouth AH, Morrow BH, Cruickshank MK, Moore PM, Kovacs MJ: Dalteparin as periprocedure anticoagulation for patients on warfarin and at high risk of thrombosis. Ann Pharmacother 2001; 35: 669–74. MEDLINE
e9. Wilson S, Morgan J, Gray L, Newman V, Anderson D: A model for perioperative outpatient management of anticoagulation in high risk patients: an evaluation of effectiveness and safety. Can J Hosp Pharm 2001; 54: 269–77.
e10. Baudo F, Ghirarduzzi A, Molinatti M et al.: Low molecular weight heparin during surgery in patients on long term oral anticoagulant treatment (OAT): A prospective observational study. Blood 2004: abstract 4063.
e11. Spyropoulos A, Turpie A, Dunn A et al.: Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: Results from the REGIMEN registry. Blood 2004; 104: abstract 709.